Key Highlights
- ARK Invest acquired 359,612 shares of Rocket Lab valued at approximately $25.1 million through three separate ETFs.
- The investment firm divested 16,422 shares of Alphabet, generating roughly $5.8 million in proceeds.
- ARK’s total Rocket Lab holdings now exceed 3.2 million shares across its portfolio, representing approximately $225 million in value.
- The upcoming Neutron rocket launch vehicle represents a critical component of Rocket Lab’s expansion strategy, with initial launch planned for late 2026.
- The firm simultaneously increased biotech exposure while reducing stakes in Twist Bioscience, 10X Genomics, and Everpure.
Cathie Wood’s investment firm ARK Invest increased its Rocket Lab holdings by $25 million on Tuesday while simultaneously reducing its stake in tech giant Alphabet.
The purchase involved 359,612 shares of Rocket Lab distributed across ARKK, ARKQ, and ARKX exchange-traded funds. This $25.1 million acquisition expands a position that ARK has been steadily accumulating as the stock experienced recent downward pressure.
After completing this transaction, ARK’s total ownership reportedly stands at over 3.2 million Rocket Lab shares spread throughout its ETF lineup, with a combined market value approaching $225 million based on current pricing.
Strategic Accumulation of Rocket Lab Shares
Rocket Lab has established its reputation through Electron, its specialized launch vehicle for small satellites, though the company’s long-term investment appeal centers heavily on Neutron.
This next-generation reusable launch system aims to capture market share within the medium-lift segment. The company has set a target launch window for Q4 2026, though management has acknowledged that qualification testing timelines could potentially delay the inaugural flight into 2027.
Beyond its launch operations, Rocket Lab continues diversifying into satellite manufacturing and communications technologies. This strategic expansion positions the company to capitalize on multiple segments within the expanding commercial and defense space sectors.
ARK’s recent acquisition follows a pattern of consistent buying during Rocket Lab’s decline from peak valuations reached in May. This sustained accumulation pattern indicates the firm remains committed to the position as shares show signs of recovery.
Alphabet Position Reduction
Concurrently, ARK liquidated 16,422 shares of Alphabet distributed between ARKQ and ARKX, generating proceeds of approximately $5.8 million.
This divestment represents a modest transaction relative to the Rocket Lab acquisition. While Alphabet maintains its status among the world’s dominant and highly profitable technology enterprises, market participants continue analyzing how artificial intelligence development might impact its core search revenue.
Google has been aggressively expanding its Gemini AI platform and developing proprietary AI processors, providing Alphabet with enhanced participation in both AI infrastructure and software ecosystems.
This comparison underscores fundamentally different investment approaches. Alphabet delivers significant cash generation currently, whereas Rocket Lab’s market valuation relies predominantly on projected growth from launch operations, Neutron deployment, and space infrastructure development.
Biotechnology Portfolio Adjustments
ARK executed multiple biotechnology transactions on Tuesday as well. The firm acquired 88,323 shares of Scribe Therapeutics valued at approximately $2.5 million, complemented by smaller acquisitions in Veracyte and Beam Therapeutics.
Regarding sales, ARK trimmed its holdings in both Twist Bioscience and 10X Genomics. Additionally, the firm sold 19,139 shares of Everpure through the ARKW fund.
The Rocket Lab transaction clearly dominated Tuesday’s trading activity. This move underscores ARK’s ongoing commitment to disruptive innovation themes spanning aerospace, biotechnology, and next-generation technology sectors.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
